Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

Clopidogrel (Noklot (300 mg)) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Noklot (300 mg)) is prescribed ...

A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...

Teva Pharmaceuticals has announced theintroduction and availability of Clopidogrel Tablets, an AB rated andbioequivalent product to Plavix Tablets (Bristol-Myers Squibb and SanofiAventis). Clopidogrel ...

Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...

-- Products: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets -- Issue: Health products -- Product safety -- What to do: If you are taking the affected products, speak with your pharmacist as ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...

Plavix Clopidogrel buy plavix 75 mg advisable to prevent blood clots after a recent heart attack or allergy. It is also important by patients with certain disorders of the incidence or blood vessels.

October 1, 2007 (Bridgewater/Princeton, NJ)-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-aventis/Bristol-Myers Squibb) for use as a ...

The potential benefits and risks of the use of dual antiplatelet therapy beyond a 12-month period in patients receiving drug-eluting stents have not been clearly established. In two trials, we ...

Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...